Background-Lysosomal carboxypeptidase, cathepsin A (protective protein, CathA), is a component of the lysosomal multienzyme complex along with ␤-galactosidase (GAL) and sialidase Neu1, where it activates Neu1 and protects GAL and Neu1 against the rapid proteolytic degradation. On the cell surface, CathA, Neu1, and the enzymatically inactive splice variant of GAL form the elastin-binding protein complex. In humans, genetic defects of CathA cause galactosialidosis, a metabolic disease characterized by combined deficiency of CathA, GAL, and Neu1 and a lysosomal storage of sialylated glycoconjugates. However, several phenotypic features of galactosialidosis patients, including hypertension and cardiomyopathies, cannot be explained by the lysosomal storage. These observations suggest that CathA may be involved in hemodynamic functions that go beyond its protective activity in the lysosome. Methods and Results-We generated a gene-targeted mouse in which the active CathA was replaced with a mutant enzyme carrying a Ser190Ala substitution in the active site. These animals expressed physiological amounts of catalytically inactive CathA protein, capable of forming lysosomal multienzyme complex, and did not develop secondary deficiency of Neu1 and GAL. Conversely, the mice showed a reduced degradation rate of the vasoconstrictor peptide, endothelin-1, and significantly increased arterial blood pressure. CathA-deficient mice also displayed scarcity of elastic fibers in lungs, aortic adventitia, and skin. Conclusions-Our results provide the first evidence that CathA acts in vivo as an endothelin-1-inactivating enzyme and strongly confirm a crucial role of this enzyme in effective elastic fiber formation.
Coincidentally, the endothelial cells of CathA knockout mice and galactosialidosis patients exhibit extensive cytoplasmic vacuolization. 7, 13 Studies of cultured fibroblasts from galactosialidosis patients demonstrated that these cells lack endothelin-degrading capacity, whereas brain autopsies showed high ET-1-specific immunoreactivity. 14, 15 Because in tissues and in the circulation, ET-1 is also cleaved by an abundant neutral endopeptidase, NEP, 16 in vivo experiments are required to understand whether CathA is a nonredundant ET-1-degrading enzyme. The previously described CathA-knockout mice are not suitable for physiological and behavioral studies because they develop progressive and diffuse edema, tremor, and ataxia due to secondary Neu1 deficiency. 13 To explore the physiological role of CathA, we generated a transgenic mouse model in which the normal CathA was replaced with a catalytically inactive enzyme that forms LMC and activates Neu1. Our studies indicate that CathA plays a nonredundant role in the regulation of blood pressure through inactivation of ET-1 and that as a component of the elastinbinding protein complex, it participates in the biogenesis of elastic fibers.
Methods Animals
A 5.4-kb fragment of the mouse CathA (Ctsa) gene containing exons 2 to 15 was amplified by an Expand long-template polymerase chain reaction (PCR) system (Roche, Basel, Switzerland) with genomic DNA of 129/Sv mice and the primers 5Ј-CCC TAA AGT TCC TAG GAG GG CATG-3Ј (I2F) and 5Ј-TTA GCG GAG GAC TCC TC TCT GCTGA-3Ј (I15R) and cloned with a TOPO XL PCR kit (Invitrogen, Carlsbad, Calif). The fragment was inserted in pBluescript vector (Stratagene, La Jolla, Calif) in front of the thymidine kinase gene. The c.571AGC3 GCA (p.S190A) mutation was generated by PCR mutagenesis with the primers 5Ј-TGG AGT CGC AGA ACG ACC CAA AGA ACA GC-3Ј (E3F), 5Ј-GCA TAT GCC TCT CCT GTC AGG AAA AGT TTG TTG-3Ј (E6R), 5Ј-CAG GAG AGG CAT ATG CTG GCA TCT ACA TCC (E6F), and 5Ј-CAC ACT CTG GGT CTT TGT TGTC-3Ј (E8R); the mutagenic nucleotide sequence is underlined. The fragments were linked by overlap amplification with primers E3F and E8R and subcloned with PstI sites. A neomycin (Neo)-resistant cassette flanked by loxP sites was inserted into the NheI site in intron 7. The targeting construct ( Figure 1A ) linearized with NotI digestion was electroporated into R1 embryonic stem (ES) cells. G418-and ganciclovir-resistant ES cells were screened for homologous recombination by PCR ( Figure  1A) with the allele-specific primers 5Ј-TCC CGG AGA TGT GCG CCA TC-3Ј (I1F) and 5Ј-CGG GGC TGC TAA AGC GCA T-3Ј (NeoR) and Southern blot ( Figure 1B ). Targeted ES clones were microinjected into C57BL/6J blastocysts and implanted into pseudopregnant female mice. Male chimeras were mated with C57BL/6J females, and offspring were genotyped by Southern blot as described above. The heterozygous mice were bred to produce homozygous CathA S190A-Neo mice or mated with FVB/N-TgN-EIIa-Cre strain (The Jackson Laboratory, Bar Harbor, Me) to remove the Neo cassette. Absence of the Neo gene was confirmed by PCR amplification of genomic DNA with the E3F and E8R primers followed by NdeI digestion ( Figure 1C ). All mice were bred and maintained in the Canadian Council on Animal Care-accredited animal facilities of the CHU Ste Justine Research Center. Approval for the experiments was granted by the animal care and use committees of the CHU Ste Justine Research Center and CHUM. CathA mRNA levels in tissues were studied by Northern blotting with a full-length [␣-32 P] dCTPlabeled mouse CathA cDNA as a probe. The expression of CathA protein was studied by Western blotting with polyclonal rabbit anti-CathA antibodies. 17
Purification of LMC
Total glycoproteins purified from 40 g of combined mouse liver and kidney tissues with affinity chromatography on concanavalin A-Sepharose 3 were dialysed against 20 mmol/L sodium acetate buffer, pH 4.75, which contained 0.15 mol/L NaCl, concentrated to Ϸ65 mg of protein per milliliter, applied on an FPLC Superose 6 column (GE Healthcare, Baie d'Urfe, Canada), and eluted with the same buffer at a flow rate of 0.4 mL/min. Thirty 0.5-mL fractions were collected and analyzed for sialidase, GAL, and carboxypeptidase activities. The molecular masses of the eluted proteins were determined with the calibration curve obtained with protein molecular weight standards (GE Healthcare).
Enzyme Assays
Sialidase, ␤-galactosidase, and ␤-hexosaminidase activities were assayed with the corresponding fluorogenic 4-methylumbelliferyl glycoside substrates as described previously. 3 Carboxypeptidase activity of CathA was measured with CBZ-Phe-Leu as a substrate 17 or by the same procedure with 0.1 mmol/L ET-1 as a substrate.
Light Microscopy of Mouse Tissues
At 1, 4, and 8 months of age, mice were anesthetized with sodium pentobarbital and euthanized by exsanguination. Lungs, spleen, brain, testis, and liver were fixed by immersion in 2.5% glutaraldehyde in 0.1 mol/L cacodylate buffer for 48 hours at 4°C. The tissues were embedded in paraffin and Epon (Hexion Specialty Chemicals, Columbus, Ohio), cut, and viewed by light microscopy.
Detection of Elastic Fibers in Mouse Skin, Lungs, and Aorta
Histological sections of skin, lungs, and aortas derived from 17week-old mice were stained with Movat's pentachrome, 18 which shows elastin as black. The distribution of black-stained material entirely overlapped with the immunostaining by the specific antielastin antibodies performed on the parallel sections. At least 5 mice were studied for each phenotype.
Isolation and Culture of Primary Neural Cells From Cerebella and Cerebra
Primary neural cell cultures were prepared from wild-type and CathA S190A mice aged 1 to 2 days. Pooled cerebra from 6 to 7 brains were passed through a nylon mesh with a 40-m pore size (BD Falcon, BD Biosciences, Mississauga, Canada) in Hank's balanced salt solution (Invitrogen). The dissociated cells were cultured in DMEM, supplemented with 10% FCS, 5 g/mL insulin, and antibiotics.
Assessment of Elastin and Other Extracellular Matrix Components Produced by Cultured Skin Fibroblasts
Skin fibroblasts isolated by collagenase digestion were cultured in DMEM, supplemented with 10% FCS and antibiotics as described previously. 6 Seven-day-old confluent cultures were fixed in 100% cold methanol. The deposition of ECM components was then detected with antibodies to tropoelastin, collagen I, and fibronectin as described previously. 19 
Measurement of Insoluble Elastin Produced by Cultured Cells
Skin fibroblasts were grown to confluence in 10-cm cell culture dishes in quadruplicates. A total of 20 Ci of [ 3 H]-valine was added to each dish along with fresh media at day 4. After 72 hours, levels of insoluble elastin were measured as described previously. 6, 19 
Blood Pressure Measurements by Radiotelemetry
Male CathA S190A-Neo mice and appropriate littermate controls were implanted with TA11PA-C10 radiotelemetry sensors (Data Sciences International, St Paul, Minn) in the left carotid artery for direct measurement of arterial pressure and heart rate as described previously. 20, 21 Immobilization stress was performed by placing the mice in a transparent restraining plastic holder routinely used for tail-cuff measurement of blood pressure. 22 At least 6 mice were studied for each genotype.
Measurement of ET-1 Degradation Rate in Mouse Blood and Tissues
CathA S190A mice and their wild-type siblings (5 mice per group) with a body weight of 40 to 45 g that had been anesthetized with urethane (1.5 g/kg) were injected intravenously with a solution of ET-1 peptide (Bachem Bioscience, King of Prussia, Pa) in saline at a dose of 10 nmol/kg body weight. After 15 minutes, blood was collected through cardiac puncture and immediately centrifuged to separate plasma. Lungs and liver were dissected and frozen in liquid nitrogen.
For peptide extraction, tissues (200 mg) were homogenized in 1 mol/L CH 3 COOH/20 mmol/L HCl. Plasma was supplemented with concentrated CH 3 COOH until the final concentration of 1 mol/L. After they were boiled for 10 minutes, samples were centrifuged at 20 000g for 10 minutes, and supernatant was applied to a Sep-Pac C18 column (Waters, Milford, Mass). Columns were washed with 3 volumes of 0.1% TFA in water, and peptides were eluted with 60% acetonitrile/0.1% TFA and lyophilized. Samples were reconstituted in 0.1% TFA in DMSO for ELISA analysis or 10% acetonitrile/0.1% TFA for tandem mass spectrometry analysis. Quantitative assay of ET-1 by ELISA was performed with a kit from IBL (Toronto, Canada).
Measurement of ET-1 With Multiple-Reaction Monitoring Tandem Mass Spectrometry
Samples were analyzed in duplicate with an 1100 Series nanoflow liquid chromatography system (Agilent Technologies, Santa Clara, Calif) and a 4000 QTrap mass spectrometer (Applied Biosystems, Foster City, Calif). The peptides were enriched on a Zorbax 300SB-C18 trap column (Agilent Technologies) and separated by Generation of CathA S190A-Neo and CathA S190A mice. A, The structure of the mouse Ctsa gene (top), the targeting construct (middle), and the mutant locus after the homologous recombination (bottom). Exons are shown as solid boxes; PGK-neomycin (Neo) cassette flanked with loxP sites (arrowheads) and PGK-thymidine kinase (TK) genes are shown as white boxes. The c.571AGCϾGCA mutation created a unique NdeI restriction site. The Neo cassette introduced a novel HindIII restriction site used for genotyping by Southern blotting with the external 5Ј probe (thick line). Restriction sites are shown as H (HindIII), S (SstII), and N (NotI). B, Targeted Ctsa locus after in vivo Cre-mediated excision of the Neo gene. C, Targeted allele-specific PCR amplification of 2040-bp DNA fragment of CathA S190A-Neo mouse with I1F and NeoR primers. NdeI digestion of PCR product generated 2 fragments of 1320 and 720 bp, respectively. D, Southern hybridization of HindIII-and SstII-digested DNA from wild-type and CathA S190A heterozygous mice in F1 progeny indicating the germline (5.6 kb) and targeted (4.1 kb) alleles. E, PCR amplification of the CathA gene in F2 progeny with primers E3F and E8R generated a 2170-bp fragment in wild-type mice, 2170-and 2220-bp fragments in heterozygous CathA S190A mice, and a 2220-bp fragment in homozygous CathA S190A mice.
reverse-phase chromatography on a PicoFrit column (New Objective, Woburn, Mass) packed with Biobasic C18. Acquired spectra were analyzed by Analyst software (Applied Biosystems).
Statistical Analysis
Statistical analysis has been performed with 2-tailed t test, Welch's modification of 2-tailed unpaired t test (Table) , and ANOVA or repeated-measures ANOVA tests.
The authors had full access to and take full responsibility for the integrity of the data. All authors have read and agree to the manuscript as written.
Results

Generation of Mice With Deficient CathA Activity
To define the physiological role of CathA activity, we generated a mouse strain with the targeted point mutation c.571AGCϾGCA in the Ctsa gene, which replaced the nucleophile of the CathA active site, Ser190, with Ala ( Figure  1 ). R1 ES cells were electroporated with the targeting vector that contained the above mutation in exon 6 and a PGK-Neo cassette inserted in intron 7. Targeted ES cells were injected into C57BL/6 embryos and transfected to pseudopregnant females. The chimeras thus obtained were bred with C57BL/6 mice to obtain germline transmission (CathA S190A-Neo strain). Mice heterozygous for CathA S190A-Neo ( Figure 1C , D) were crossed with mice carrying a Cre-expressing transgene 23 to excise the PGK-Neo cassette. Littermates were genotyped for the presence of the PGK-Neo gene and CathA S190A allele ( Figure 1E ) and mated with each other to obtain animals homozygous for the CathA S190A allele.
Both the CathA S190A-Neo and CathA S190A mice were vital and fertile, grew normally, and had a normal lifespan, but they had almost zero CathA activity measured with CBZ-PheLeu (Table) or ET-1 (not shown) in kidney, livers, and lungs, consistent with the presence of the Ser190Ala point mutation. 24 CathA S190A mice, however, had normal sialidase activity, whereas in tissues of CathA S190A-Neo mice, the sialidase activity was reduced to Ϸ10% (Table) . CathA mRNA levels were reduced dramatically in tissues of CathA S190A-Neo mice, consistent with the previously reported hypomorphic effect of the Neo gene, 25, 26 whereas CathA S190A mice expressed normal CathA mRNA levels (Figure 2A ). Both Western blotting and immunohistochemistry showed normal levels of CathA protein in the tissues of CathA S190A mice ( Figure 2B and 2C) .
To confirm that the inactive S190A CathA mutant is capable of forming a complex with Neu1 and GAL, we performed a gel-filtration analysis of concentrated glycoprotein extracts from the combined kidney and liver tissues of the wild-type, CathA S190A , and CathA S190A-Neo animals. In the tissue extracts of the wild-type mice, both an Ϸ1200-kDa LMC and a 120-kDa CathA homodimer 6, 17 were detected by the presence of enzymatic activity peaks that eluted from the column with correspondingly appropriate retention times ( Figure 2D , peaks I and II). Similar profiles for GAL and Neu1 activities were also observed in the fractions obtained by gel filtration of the tissue extracts of CathA S190A mice, but no carboxypeptidase activity was detected ( Figure 2D ), although CathA protein was present in the expected amount according to Western blot analysis ( Figure 2D , inset). Both CathA activity and protein were absent from the fractions collected after gel filtration of the tissue extracts of CathA S190A-Neo mice (not shown).
CathA S190A Mice Have Pathological Changes in Elastin-Rich Tissues
Pathological examination of CathA S190A mice performed at the age of 1 and 8 months did not reveal any gross changes in the visceral organs. Similarly, microscopic investigation of tissue sections ( Figure 3A ) showed normal morphology in most tissues, including those with high expression of CathA activity, such as kidney, liver, testis, and brain. However, light microscopic histochemical examination demonstrated pathological changes in elastin-rich tissues such as skin, arteries, and lungs ( Figure 3B ). The dermis of CathA S190A mice showed a significant decrease in elastic fibers as detected by the pentachrome Movat method ( Figure 3B ) and by immunohistochemistry with specific anti-elastin antibodies ( Figure   Table. CathA, GAL, and Sialidase Activities in Tissue Extracts of CathA S190A-Neo Mice, CathA S190A Mice, and Their Wild-Type Littermates
Fraction
CathA S190A-Neo WT CathA S190A WT Data show meanϮSD of measurements in 15 mice. Activity of the control lysosomal enzyme N-acetyl-␤-D-glucosaminidase was not statistically different between the strains. WT indicates wild type.
*Significantly different from wild-type by Welch's modification of 2-tailed unpaired t test (PϽ0.01). Figure I) . The elastic arteries of CathA S190A mice exhibited a peculiar reduction of elastic fibers in the tunica adventitia. The deficiency in elastic fibers was also noted within the alveolar septae of the lung in CathA S190A mice and coincided with an apparent enlargement of the alveolar diameter, which resembled an initial stage of the emphysema. Finally, cultured skin fibroblasts of CathA S190A mice also showed impaired deposition of insoluble elastin, as measured by [ 3 H]-valine incorporation, and a discriminatory reduction in the number of elastic fibers, as assessed by quantitative immunohistochemistry. Of note, cultured skin fibroblasts of CathA S190A mice produced normal levels of fibronectin and collagen ( Figure 3D ).
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Changes in Cardiovascular Function in CathA-Deficient Mice
To test the hypothesis that CathA, as the ET-1-degrading enzyme, is involved in hemodynamic regulation, we measured heart rate, blood pressure (BP), natriuresis, and diuresis in CathA S190A and control mice by radiotelemetry and metabolic cages. BP and heart rate were measured at rest (over a 10-day period), after the stress caused by 30 minutes of immobilization or after intravenous injection of ET-1 (0.1 nmol per kg of body weight). The same measurements were performed after the mice were challenged with a high-salt diet (8% NaCl for 3 weeks). On a normal diet, CathA S190A mice had significantly (Pϭ0.004) higher day ( Figure 4A ) and night (not shown) levels of both diastolic BP (day 1, 99.5Ϯ2.4, day 2, 97.3Ϯ2.5, and day 3, 95.7Ϯ1.5 mm Hg) and systolic (day 1, 137.6Ϯ3.2, day 2, 133.9Ϯ2.9, and day 3, 132.1Ϯ1.9 mm Hg) BP than their wild-type siblings (day 1, 90.7Ϯ1.3, day 2, 87.3Ϯ0.6, and day 3, 87.4Ϯ1.3 mm Hg, and day 1, 124.0Ϯ1.8, day 2, 119.2Ϯ1.9, and day 3, 119.2Ϯ1.8 mm Hg, respectively), whereas heart rates were the same (not shown). CathA S190A mice also showed on average a lower increase in BP during immobilization stress, although the difference compared with the wild-type group did not reach statistical significance ( Figure 4B ). A significant (Pϭ0.038) difference in systolic and diastolic BP between wild-type and CathA S190A mice was also detected for the mice challenged by a high-salt diet ( Figure 4D ) and between these groups in the immobilization stress experiment ( Figure 4E) . CathA S190A mice kept on a high-salt diet also consumed more water and produced more urine than their wild-type siblings (not shown) and showed a different response to the intravenous injections of ET-1. Although in wild-type mice, intravenous administration of ET-1 resulted in an Ϸ40% increase in BP that lasted for at least 50 minutes, BP in the CathA S190A mice remained mostly unchanged ( Figure 4F ).
Figure 2. Expression of LMC components in CathA-deficient mice. A, Northern blot analysis of total liver RNA from
CathA S190A-Neo and CathA S190A mice (Ϫ/Ϫ) and their wild-type littermates (ϩ/ϩ) hybridized with CathA cDNA and mouse ␤-actin cDNA. B, Western blotting of CathA protein in tissues of wildtype (ϩ/ϩ) and CathA S190A (Ϫ/Ϫ) mice. MW indicates molecular weight. C, Immunohistochemical detection of CathA protein in lung tissues of a wild-type and CathA S190A mouse. Slides were stained with antibodies against the 32-kDa protein chain of CathA (CathA) or secondary antibodies only (Control). Magnification ϫ100. D, FPLC gel filtration and Western blot analysis (insets) of concentrated glycoprotein extracts from liver and kidney tissues of mice homozygous for the CathA S190A allele (upper panel) and their wild-type littermates (lower panel). Glycoprotein 
CathA-Deficient Mice Have Decreased Degradation Rate of ET-1
Cultured embryonic brain cells of CathA S190A mice secreted a significantly higher level of ET-1 ( Figure 5A) ; however, the comparisons of ET-1 levels in tissues of CathA S190A mice and their wild-type siblings measured with both ELISA ( Figure  5B ) and immunohistochemistry (not shown) were not conclusive. To determine whether the ET-1 degradation rate was different for the wild-type and CathA-deficient mice, we measured the concentration of the exogenous ET-1 in lungs and plasma 15 minutes after the intravenous injection (0.1 nmol per kg of body weight). Because antibody-based assays could not differentiate between the active full-length ET-1 peptide and the inactive peptide generated from ET-1 by CathA and lacking the C-terminal Trp residue, the ET-1 levels were assayed by multiple-reaction monitoring tandem mass spectrometry. The ET-1 concentration was determined by spiking the samples with known concentrations of ET-1 standard and comparing the mass spectrometry intensities to those of nonspiked samples. The data showed that 15 minutes after the intravenous ET-1 injection, its concentration in lungs ( Figure 5C ) or plasma (not shown) was on average 3-fold higher in CathA S190A mice than in their wild-type siblings, which suggests that in CathA S190A mice, the degradation rate of ET-1 is considerably reduced.
Discussion
Despite the fact that ubiquitously expressed lysosomal carboxypeptidase, CathA, was described almost 7 decades ago, 27 its biological function related to carboxypeptidase activity remained mainly unknown. Mice with targeted disruption of the Ctsa gene and human sialidosis patients with CathA mutations develop splenomegaly, skeletal abnormalities, and neuronal death. 7, 13 The present results show that these defects are caused by the secondary deficiency of Neu1 and not by the lack of CathA activity.
However, mutant mice in the present study that expressed normal levels of a catalytically inactive CathA protein showed a significant loss of elastic fibers in elastin-rich tissues, such as the skin and the tunica adventitia of elastic arteries. Also, the lungs, which are normally rich in elastic fibers, showed an unusual enlargement of the alveolar sacs and thinning of the alveolar septae. Previously, we have identified that CathA is a component of the elastin-binding protein complex, a nonintegrin cell-surface receptor expressed in all elastin-producing cells. 6 The complex also contains Neu1 and the elastin-binding protein (EBP), an alternatively spliced product of the GAL gene. 28 We also reported that cultured fibroblasts from galactosialidosis patients produce sufficient amounts of microfibrillar components and tropoelastin, which fail to assemble into elastic fibers. 6 The present study constitutes the first in vivo demonstration that CathA activity in the elastin-binding protein complex is a prerequisite for the efficient assembly of elastic fibers.
The development of arterial hypertension, previously reported in galactosialidosis but not in sialidosis patients, 29, 30 is another clinical feature that could not be explained just on the basis of impaired lysosomal catabolism of sialylated glycoconjugates. We show that CathA S190A mice fed a normal and a high-salt diet had elevated BP compared with their wild-type siblings. The heart rate values were similar for both strains, which suggests that the observed difference in BP relates to a vascular effect. Because previous data showed that CathA can inactivate ET-1 in vitro, 11 the elevated BP in CathA-deficient mice could be attributed to higher circulating levels of this peptide. Indeed, mass spectroscopy studies showed that these mice had a reduced degradation rate of ET-1 in blood and tissues.
Elevated ET-1 values have been observed previously in vascular and cardiovascular disorders such as acute myocardial infarction, congestive heart failure, ischemia, atherosclerosis, and hypercholesterolemia, as well as in patients with atrial and pulmonary hypertension. 31 ET-1-deficient mice show abnormal manifestations in fetal development and hemodynamics, 32 whereas overexpression of human ET-1 in Figure 4 . Radiotelemetry measurements of systolic BP, diastolic BP, and mean arterial pressure (MAP). A, Diastolic BP in CathA S190A mice (▫) and wild-type mice (⅙), systolic BP in CathA S190A mice (‚), and wild-type mice (ƒ) were recorded continuously under basal conditions in mice fed a normal salt diet. MAP was also recorded before, during, and after a 30-minute immobilization stress (B) or after the intravenous injection of ET-1 at a dose of 0.1 nmol per kg of body weight (C). The same measurements were performed after the mice were challenged with a high-salt diet (D, E, and F). P values report differences between wild-type and CathA S190A mice. Data were analyzed with a general linear model (repeated-measures ANOVA). At least 6 mice were studied for each genotype. mice caused vascular remodeling and endothelial dysfunction but no increase in BP. 33, 34 The latter result is contrary to the present findings, which demonstrated elevated basal BP levels in CathA-deficient mice. One possible explanation for the difference in BP between CathA-deficient mice with reduced capacity of ET-1 degradation and the transgenic mice stably secreting high levels of ET-1 could be the compensatory suppression of the renin-angiotensin system previously shown in men systemically infused with ET-1. 35 In addition, CathA has a high activity against Ang I, converting it to Ang 1-9, which competes with Ang I in the reaction catalyzed by angiotensin-converting enzyme and potentiates bradykinin action on its B 2 receptor. 9, 36, 37 It is tempting to speculate, therefore, that the CathA-deficient mice would fail to generate this peptide and to release Ang II through the alternative stepwise pathway. Atrial natriuretic peptide is another regulator of BP that can be affected by the increased levels or reduced degradation rate of ET-1. 38 Although in the present study, we did not directly measure levels of atrial natriuretic peptide, the increased urinary volume and water consumption in CathA-deficient mice challenged by a high-salt diet are consistent with higher levels of this hormone.
Together, the present results demonstrate that CathA, in addition to its known role in the lysosome, is an important factor that contributes to BP regulation and normal development of elastic fibers, a crucial component of the cardiovascular and respiratory systems. Figure 5 . A, Levels of ET-1 peptide (pg/mL media) measured by ELISA in conditioned media from cultured cerebral cells of wildtype (ϩ/ϩ) and CathA S190A (Ϫ/Ϫ) mice. The graph shows the data from 2 independent experiments performed on 2 occasions. Each time, primary neural cell cultures were prepared with pooled cerebra from 6 to 7 brains of wild-type and CathA S190A newborn mice aged 1 to 2 days. After 5 days, the ET-1 concentration in the culture media was measured by ELISA. Five parallel measurements were performed for each sample. **PϽ0.05 (t test). B, Levels of ET-1 peptide (pg/mg protein) measured by ELISA in tissue extracts of wild-type (ϩ/ϩ) and CathA S190A (Ϫ/Ϫ) mice. Data represent mean and SE of 3 independent experiments. C, Representative multiple-reaction monitoring tandem mass spectrometry chromatograms of ET-1 peptide from peptide extracts from lungs of wild-type (red line) and CathA S190A (blue line) mice collected 15 minutes after intravenous injection of ET-1.
